China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical study to evaluate the efficacy and safety of HT-101 injection combined with HT-102 injection in patients with chronic hepatitis B.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129961
Registration Time: 2026/08/12
Type: Interventional study
Primary Sponsor: Nanfang Hospital, Southern Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=294886
Published by HT Digital Content Services with permission from Health Daily Digest....